Search results for "hospital cost"

showing 10 items of 17 documents

Photobiomodulation therapy reduces postoperative pain after third molar extractions: A randomized clinical trial

2020

Background To assess the efficacy of PBMT on reducing postoperative pain scores in patients submitted to third molar extractions. Material and Methods A randomized controlled trial (ReBEC:RBR-94BCKZ) was designed according to the SPIRIT and followed the CONSORT. Patients were randomly allocated according to control or PBMT groups. PBMT consisted of the application of GaAlAs laser (808nm;50mW) applied in six points (1.23 min;11 J/cm2) after extraction. Pain scores were assessed using the Visual Analogue Scale (VAS) in millimeters evaluated after 6 (T6), 24 (T24), and 48 (T48) hours. The Wilcoxon Mann–Whitney test was used to check for possible associations between VAS scores and treatment gr…

AdultMolarVisual analogue scalepublic policyPostoperative painmaxillofacial injurieslaw.inventionRandomized controlled triallawHumansMedicineIn patientLow-Level Light TherapyGeneral DentistryUNESCO:CIENCIAS MÉDICASPain MeasurementPain Postoperativebusiness.industryResearchMean ageOtorhinolaryngologyAnesthesiaTooth ExtractionMolar ThirdSurgeryhospital costOral SurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

What is the impact of rerouting a cancer diagnosis from emergency presentation to GP referral on resource use and survival? Evidence from a populatio…

2018

Background Studies on alternative routes to diagnosis stimulated successful policy interventions reducing the number of emergency diagnoses and associated mortality risk. A dearth of evidence on the costs of such interventions might prevent new policies from achieving more ambitious targets. Methods We conducted a retrospective cohort study on the population of colorectal (88,051), breast (90,387), prostate (96,219), and lung (97,696) cancer patients diagnosed after a GP referral or an emergency presentation and reported in the Cancer Registry of England. Resource use and survival were compared 1 year before and 5 years after diagnosis (3 years for lung), including the costs of GP referrals…

Emergency Medical ServicesCancer ResearchSurvival0302 clinical medicineNeoplasmsEmergency medical services1306030212 general & internal medicineMedical diagnosisReferral and Consultationeducation.field_of_study1311Health Care CostsEarly diagnosilcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensPrognosisEarly diagnosisPrimary careRoute to diagnosisRoute to diagnosiOncologyPopulation Surveillance030220 oncology & carcinogenesisHealth ResourcesHospital costResearch Articlemedicine.medical_specialty2730ReferralEarly diagnosis; Emergency; Hospital costs; Primary care; Route to diagnosis; Survival; Oncology; Genetics; Cancer ResearchPopulationlcsh:RC254-28203 medical and health sciencesGeneticGeneral PractitionersGeneticsmedicineHumanseducationLung cancerbusiness.industryCancerRetrospective cohort studymedicine.diseaseCancer registryEmergency medicineEmergencyHospital costsbusinessNeoplasms/diagnosis
researchProduct

Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy

2020

Abstract Background and aims Nonalcoholic steatohepatitis (NASH) may progress to advanced liver disease (AdvLD). This study characterized comorbidities, healthcare resource utilization (HCRU) and associated costs among hospitalized patients with AdvLD due to NASH in Italy. Methods and results Adult nonalcoholic fatty liver disease (NAFLD)/NASH patients from 2011 to 2017 were identified from administrative databases of Italian local health units using ICD-9-CM codes. Development of compensated cirrhosis (CC), decompensated cirrhosis (DCC), hepatocellular carcinoma (HCC), or liver transplant (LT) was identified using first diagnosis date for each severity cohort (index-date). Patients progres…

Liver CirrhosisMaleTime FactorsCirrhosisDatabases FactualEndocrinology Diabetes and MetabolismMedicine (miscellaneous)ComorbidityHospital Cost030204 cardiovascular system & hematologyLiver diseasePatient Admission0302 clinical medicineRetrospective StudieNon-alcoholic Fatty Liver DiseaseRisk FactorsNonalcoholic fatty liver diseaseAmbulatory CarePrevalenceMedicineHospital Costseducation.field_of_studyDrug CostNutrition and DieteticsLiver NeoplasmsNASHMiddle AgedPrognosisItalyLiver NeoplasmHepatocellular carcinomaCohortDisease ProgressionHealth ResourcesFemaleCardiology and Cardiovascular MedicineHumanAdultmedicine.medical_specialtyCarcinoma HepatocellularTime FactorAdolescentCostPrognosiLiver CirrhosiPopulation030209 endocrinology & metabolismPharmacyDrug CostsYoung Adult03 medical and health sciencesNAFLDInternal medicineHumanseducationAgedRetrospective StudiesHealth Resourcebusiness.industryRisk Factormedicine.diseaseComorbiditydigestive system diseasesLiver TransplantationHCRUbusinessAdministrative Claims HealthcareNutrition, Metabolism and Cardiovascular Diseases
researchProduct

A data mining approach for grouping and analyzing trajectories of care using claim data: the example of breast cancer

2013

International audience; BACKGROUND: With the increasing burden of chronic diseases, analyzing and understanding trajectories of care is essential for efficient planning and fair allocation of resources. We propose an approach based on mining claim data to support the exploration of trajectories of care. METHODS: A clustering of trajectories of care for breast cancer was performed with Formal Concept Analysis. We exported Data from the French national casemix system, covering all inpatient admissions in the country. Patients admitted for breast cancer surgery in 2009 were selected and their trajectory of care was recomposed with all hospitalizations occuring within one year after surgery. Th…

MaleDatabases FactualInsurance Claim Review02 engineering and technologyCarecomputer.software_genreHealth informatics0302 clinical medicine0202 electrical engineering electronic engineering information engineeringFormal concept analysisMedicine[ SHS.ECO ] Humanities and Social Sciences/Economies and finances030212 general & internal medicineHospital Costs[ SDV.BIBS ] Life Sciences [q-bio]/Quantitative Methods [q-bio.QM][SHS.ECO] Humanities and Social Sciences/Economics and FinanceComputingMilieux_MISCELLANEOUS[INFO.INFO-BI] Computer Science [cs]/Bioinformatics [q-bio.QM]Cancer[SDV.BIBS] Life Sciences [q-bio]/Quantitative Methods [q-bio.QM]Health PolicyFormal concept analysisMiddle Aged[SHS.ECO]Humanities and Social Sciences/Economics and Finance[SDV.BIBS]Life Sciences [q-bio]/Quantitative Methods [q-bio.QM]Hospitals3. Good healthComputer Science ApplicationsClaim dataFemaleData miningFranceTrajectory of careResearch ArticleHealth InformaticsBreast Neoplasms03 medical and health sciencesInsurance Claim ReviewBreast cancerbreast cancer020204 information systems[ INFO.INFO-BI ] Computer Science [cs]/Bioinformatics [q-bio.QM]HumansData miningAgedbusiness.industryCancerAnalysing trajectoriesmedicine.diseaseData science[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM]businesscomputer
researchProduct

[Cost of hospital-based management of acute myeloid leukemia: from analytical to procedure-based tarification]

2006

International audience; The confrontation of the macro- and micro-economic approaches of hospital costs is a recurrent question, in particular for pathologies where length of stay is highly variable, like acute myeloid leukemias (AML). This monocentric and retrospective study compares direct hospital medical costs of induction and relapse treatment sequences for AML, valued according to four different approaches: the analytic accounting system of our hospital, the French Diagnosis Related Group (DRG) cost databases of hospital discharges (readjusted, or not, to actual hospital stay duration), and official tariffs from the new French DRG prospective payment system. The average cost of hospit…

MaleMESH: Remission InductionMESH : Retrospective StudiesMESH : RecurrenceMESH: Leukemia MyeloidMESH: Length of StayRecurrence[ SDV.IMM ] Life Sciences [q-bio]/ImmunologyMESH : FemaleHospital Costshealth care economics and organizationsMESH: Diagnosis-Related GroupsMESH: Hospital CostsMESH: Middle AgedRemission InductionMESH : Acute DiseaseMiddle AgedMESH : AdultMESH : Diagnosis-Related GroupsMESH : Length of StayLeukemia MyeloidAcute DiseaseMESH : Leukemia MyeloidMESH: Acute Disease[SDV.IMM]Life Sciences [q-bio]/ImmunologyFemaleMESH : Prospective Payment SystemFranceAdultAdolescent[SDV.IMM] Life Sciences [q-bio]/ImmunologyMESH : MaleMESH : Hospital CostsMESH: Prospective Payment SystemMESH : AdolescentHumansMESH : Middle AgedMESH : FranceDiagnosis-Related GroupsRetrospective StudiesMESH: AdolescentMESH : Remission InductionMESH: HumansProspective Payment SystemMESH : HumansMESH: Retrospective StudiesMESH: AdultLength of StayMESH: MaleMESH: RecurrenceMESH: FranceMESH: Female
researchProduct

Cardiac troponin I and T: Exploring popularity with Google Trends

2020

The implementation of high-sensitivity cardiac troponin T (hs-cTnT) assays and a cutoff based on the 99th cTnT percentile in the evaluation of patients with suspected acute coronary syndrome has not been uniform due to uncertain effects on health benefits and utilization of limited resources.Clinical and laboratory data from patients with chest pain or dyspnea at the emergency de¬partment (ED) were evaluated before (n = 20516) and after (n = 18485) the lowering of the hs-cTnT cutoff point from 40 ng/L to the 99th hs-cTnT percentile of 14 ng/L in February 2012. Myocardial infarction (MI) was diagnosed at the discretion of the attending clinicians responsible for the patient.Following lowerin…

Malemedicine.medical_specialtyCardiac troponinMEDLINEGoogle TrendsClinical CardiologyElectrocardiographyPatient AdmissionTroponin TPredictive Value of TestsInternal medicinemedicineHumansHospital MortalityAcute Coronary SyndromeHospital CostsIntensive care medicineAgedRetrospective StudiesAged 80 and overCardiac troponins popularity Google Trendspopularitybusiness.industryTroponin IGeneral MedicineMiddle AgedPopularityHospitalsHospitalizationSurvival RateCardiologyFemaleCardiac troponinsCardiology and Cardiovascular MedicinebusinessEmergency Service HospitalBiomarkersFollow-Up Studies
researchProduct

Hospitalisation Cost of Patients with Diabetic Foot Ulcers in Valencia (Spain) in the Period 2009–2013: A Retrospective Descriptive Analysis

2018

Ulcers are the main cause of hospitalisation and clinical complications in patients with diabetes. We analyse the length and cost of hospital stay of patients with diabetic foot ulcers, taking into consideration that hospitalisation and, if necessary, amputation represent the greatest area of expense to the healthcare system for such patients. This analysis focuses on the treatment provided to these patients in public hospitals in the region of Valencia (Spain), registered in the Spanish Minimum Basic Data Set, during the period 2009&ndash

Malemedicine.medical_specialtyCostHealth Toxicology and Mutagenesismedicine.medical_treatmentcostslcsh:Medicine030209 endocrinology & metabolismÚlceresArticle03 medical and health sciences0302 clinical medicineMBDS (Minimum Basic Data Set)Diabetes mellitusmedicineHumansIn patient030212 general & internal medicineHospital CostsulcersSocioeconomic statusAgedRetrospective StudiesDiabetisDescriptive statisticsbusiness.industrylcsh:RPublic Health Environmental and Occupational HealthMiddle Agedmedicine.diseaseDiabetic footDiabetic FootHospitalsHospitalizationAmputationSpainEmergency medicineFemalebusinessHospital staydiabetic footHealthcare systemInternational Journal of Environmental Research and Public Health
researchProduct

Severe third molar complications including death-lessons from 100 cases requiring hospitalization.

2006

Purpose In this study we investigated patients that were hospitalized due to third molar (M3) complications. Specifically we analyzed frequency, age distribution, and outcome with respect to the M3 clinical status. Patients and Methods We set up a prospective cohort study and included 100 subjects admitted for management of acute M3-associated complications. The clinical status of the M3 was defined as 1 ) prophylactic M3 removal, 2 ) therapeutic (nonelective) M3 removal, or 3 ) M3 present at the time of admission. Outcome variables were clinical infection markers (C-reactive protein, leukocyte counts) and economic parameters (treatment costs, length of hospital stay, and days of disability…

MolarAdultMalemedicine.medical_specialtyPericoronitisAdolescentMyocardial InfarctionLeukocyte CountsStatistics NonparametricLeukocyte CountFatal OutcomeCost of IllnessGermanySickness Impact ProfilemedicineHumansSurgical Wound InfectionMyocardial infarctionProspective StudiesHospital CostsProspective cohort studyAgedAged 80 and overbusiness.industryLength of StayMiddle Agedmedicine.diseaseProphylactic SurgerySurgeryC-Reactive ProteinOtorhinolaryngologyTooth ExtractionSurgeryObservational studyFemaleMolar ThirdPericoronitisOral SurgeryComplicationbusinessJournal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
researchProduct

Evaluation économique de la prématurité : une première année de vie aux enjeux majeurs : le cas de la France

2016

This thesis focuses on a first economic assessment of prematurity in France. Prematurity is defined as occurring before 37 weeks of gestation. It is increasing in France and worldwide. If the issues of public health are already well identified, medical care and collective choices concerning prematurity matters also involve significant economic challenges. The first part of this thesis attempts to present the public health issues of prematurity and highlights the remaining efforts required to provide prevention in France. It then considers economic issues on the use of socially fairer resources dedicated to perinatal health in a context where current health expenditure is rising. Assessment …

PréventionSNIIRAMCoûts extrahospitaliersGestational ageAnalyse économique[SHS.ECO]Humanities and Social Sciences/Economics and FinanceCoûts hospitaliersEconomic analysesAge gestationnel[ SHS.ECO ] Humanities and Social Sciences/Economies and financesNon-hospital costs[SHS.ECO] Humanities and Social Sciences/Economics and FinanceHospital costsPrematurityPrématurité
researchProduct

Economic costs associated with acute attacks and long-term management of hereditary angioedema.

2010

Background Hereditary angioedema (HAE) is a rare autosomal dominant disorder characterized by recurrent acute attacks of swelling of the larynx, abdomen, and periphery. Objective To assess the economic burden associated with acute attacks and long-term management of HAE. Methods Burden was assessed via a Web-based survey of HAE patients (≥18 years old) that solicited information on attack characterization, short-term treatment, long-term disease management, impact on work, and patient costs. A standardized instrument, the Work Productivity and Activity Impairment questionnaire, was included to assess impact on work productivity. Standard medical costs and US average wage costs were assigned…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyEmergency Medical Servicesmedia_common.quotation_subjectImmunologyWageDrug CostsIndirect costsCost of IllnessEconomic costSurveys and QuestionnairesLong term managementmedicineImmunology and AllergyHumansDisease management (health)Hospital CostsProductivityhealth care economics and organizationsmedia_commonbusiness.industryAngioedemas HereditaryEmergency departmentHealth Care Costsmedicine.diseaseHospitalizationHealth Care SurveysEmergency medicineHereditary angioedemaAcute DiseasePhysical therapyFemalebusinessAnnals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology
researchProduct